| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1667.9B | ¥1664.5B | +0.2% |
| Operating Income | ¥59.2B | ¥114.5B | -48.3% |
| Ordinary Income | ¥63.7B | ¥110.7B | -42.5% |
| Net Income | ¥45.5B | ¥87.2B | -47.8% |
| ROE | 3.3% | 6.5% | - |
FY2026 Q3 results showed revenue near-flat at 166.79B yen (YoY +0.2%) while profitability deteriorated sharply with operating income of 5.92B yen (YoY -48.3%), ordinary income of 6.37B yen (YoY -42.5%), and net income of 4.55B yen (YoY -47.8%). The company experienced severe margin compression across all levels: operating margin declined 333 basis points to 3.5% from 6.9%, ordinary income margin fell 283 basis points to 3.8%, and net profit margin dropped 251 basis points to 2.7%. The deterioration stemmed primarily from gross profit erosion of approximately 4.97B yen and selling, general, and administrative expense growth of 2.8%, creating negative operating leverage. Non-operating income of 1.58B yen, including interest income of 391M yen and dividend income of 372M yen, provided partial offset but was insufficient to compensate for core operational weakness. Total assets increased 7.3% to 231.27B yen while asset turnover declined from 0.772 to 0.721, reflecting efficiency headwinds driven by inventory accumulation of 6.17B yen (21.2% increase). The company increased both long-term borrowings by 4.5B yen and short-term borrowings by 1.0B yen to support capital expenditure and working capital needs, though liquidity remains robust with cash of 52.85B yen. Full-year guidance projects revenue of 225.0B yen (YoY +1.5%), operating income of 10.0B yen (YoY -36.0%), and net income of 6.0B yen, requiring substantial margin recovery in Q4.
[Profitability] Operating margin of 3.5% represents a sharp 333 basis point contraction from 6.9% YoY, driven by gross margin erosion and SGA expense expansion of 2.8% against flat revenue growth. Net profit margin of 2.7% declined 251 basis points from 5.2%, reflecting both operational deterioration and higher cost structure. ROE of 3.3% decreased from prior period, decomposed as net margin of 2.7% times asset turnover of 0.721 times financial leverage of 1.66, with margin compression as the primary deterioration factor. Interest coverage ratio of 11.93 times indicates adequate debt servicing capacity despite increased borrowings. [Efficiency] Asset turnover declined to 0.721 from 0.772, primarily attributable to inventory accumulation of 6.17B yen which increased 21.2% to 35.35B yen, suggesting demand deceleration or production build-up. Working capital increased substantially due to inventory growth, constraining cash conversion efficiency. [Financial Health] Equity ratio of 60.4% and current ratio of 250.8% demonstrate solid financial stability. Quick ratio of 184.7% indicates strong liquidity excluding inventory. Debt-to-equity ratio of 0.66 and debt-to-capital ratio of 23.3% reflect conservative capital structure. Cash and deposits of 52.85B yen provide 7.6 times coverage of short-term borrowings of 7.0B yen, ensuring ample liquidity buffer. [Balance Sheet Changes] Total assets increased 15.82B yen (7.3%) to 231.27B yen, with inventory rising 6.17B yen, property plant and equipment increasing 3.05B yen (4.3%), and other current assets expanding 1.76B yen. Long-term borrowings increased 4.5B yen (14.5%) to 35.5B yen and short-term borrowings rose 1.0B yen (16.7%) to 7.0B yen. Accounts payable grew 3.81B yen (13.4%) to 32.18B yen, suggesting extended payment terms. Foreign currency translation adjustments contributed 3.85B yen to other comprehensive income, adding 4.28B yen (22.8%) to accumulated other comprehensive income.
Cash and deposits remained essentially flat at 52.85B yen, declining only 0.04% or 20M yen YoY, despite significant operational challenges and capital deployment. The stability in cash position masks underlying working capital pressures from inventory accumulation of 6.17B yen and accounts receivable growth of approximately 1.0B yen, which absorbed substantial operating cash generation. Accounts payable increased 3.81B yen, providing partial funding offset through extended supplier credit terms. Capital expenditure activities are evidenced by property plant and equipment increase of 3.05B yen, with construction in progress of 10.93B yen suggesting ongoing facility expansion or equipment installation. Financing activities included long-term borrowing increase of 4.5B yen and short-term borrowing expansion of 1.0B yen, totaling 5.5B yen in debt proceeds that funded capital investment and working capital buildup. The combination of stable cash, increased working capital requirements, and debt-funded investment suggests operating cash flow likely covered core operations and dividends but required external financing for growth capital and inventory buildup. Cash coverage of short-term liabilities remains strong at 7.6 times short-term borrowings, indicating no near-term liquidity stress despite working capital headwinds. The key forward indicator is inventory normalization: successful reduction would release substantial cash and improve conversion cycle metrics.
Ordinary income of 6.37B yen versus operating income of 5.92B yen reflects net non-operating contribution of approximately 450M yen, comprising primarily financial income and equity method gains. Non-operating income of 1.58B yen included interest income of 391M yen and dividend income of 372M yen as main components, representing approximately 0.9% of revenue and indicating moderate contribution from financial assets and investments. Non-operating expenses totaled 1.12B yen, with interest expense of 496M yen being the principal item, resulting in interest coverage of 11.93 times which demonstrates comfortable debt servicing capacity. The non-operating net positive contribution provided partial cushion for operational weakness but was insufficient to offset the 5.53B yen operating income decline. From an accruals perspective, the substantial inventory increase of 6.17B yen and accounts receivable growth suggest significant working capital accruals that likely exceeded reported net income, raising questions about cash conversion quality. The divergence between asset growth (7.3%) and revenue growth (0.2%) indicates capital is being deployed with deteriorating returns. While cash remained stable, the combination of margin compression, negative operating leverage, and working capital absorption suggests earnings quality has weakened and that reported profits may not fully convert to free cash flow without inventory correction. The reliance on non-operating income to partially offset core operational deterioration is not sustainable and highlights the urgency of operational margin recovery.
Margin compression risk is acute with operating margin at 3.5%, below the 5% threshold that typically signals operational stress, creating vulnerability to further cost increases or pricing pressure. Inventory accumulation of 6.17B yen (21.2% increase) poses dual risks of obsolescence if demand remains weak and continued working capital cash drain, particularly if product lifecycles shorten or customer specifications change. Revenue stagnation at 0.2% growth combined with 2.8% SGA expense growth creates negative operating leverage, requiring either revenue acceleration or aggressive cost reduction to restore profitability. Return on invested capital of 3.3%, substantially below cost of capital, indicates capital allocation efficiency has deteriorated and raises questions about the returns on recent 3.05B yen PPE investment and 10.93B yen construction in progress. Customer concentration or end-market cyclicality risk exists if primary segments face extended weakness, as evidenced by the Connector segment operating margin of 6.1% and Interface Solution segment margin of only 1.1%, both likely below sustainable levels.
[Industry Position] (Reference - Proprietary Analysis) Operating margin of 3.5% falls significantly below the manufacturing industry median of 7.3% and below the 25th percentile of 4.6%, placing the company in the lower quartile for operational efficiency. Net profit margin of 2.7% similarly lags the industry median of 5.4% and approaches the lower quartile boundary of 3.5%, indicating below-average profitability realization. ROE of 3.3% trails the manufacturing median of 4.9% while remaining above the 25th percentile of 2.8%, suggesting equity returns are compressed but not yet in the bottom quartile. Revenue growth of 0.2% significantly underperforms the industry median of 2.8% and falls well below the first quartile threshold of negative 0.9%, indicating relative market share loss or end-market weakness. The equity ratio of 60.4% compares favorably to the industry median of 63.9%, positioning near the median with moderate financial conservatism. Current ratio of 2.51 falls below the industry median of 2.67 but remains within the interquartile range of 2.00 to 3.56, indicating adequate but not exceptional short-term liquidity. The company's profitability metrics are notably weaker than industry central tendencies, while financial health indicators remain reasonably aligned with sector norms, suggesting operational challenges rather than structural financial stress. Industry: Manufacturing (65 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis.
Significant operational margin deterioration from 6.9% to 3.5% operating margin, representing 333 basis point compression, has positioned profitability in the lower quartile of manufacturing peers and signals urgent need for gross margin recovery or cost structure realignment to restore competitive positioning. Inventory accumulation of 6.17B yen increasing 21.2% against near-flat revenue growth suggests demand-supply imbalance requiring either successful demand recovery or aggressive production adjustment, with resolution critical to working capital normalization and free cash flow generation in subsequent quarters. Capital allocation efficiency has declined materially as evidenced by ROIC of 3.3%, ROA of 2.0%, and asset turnover deterioration to 0.721, while concurrent PPE investment of 3.05B yen and construction in progress of 10.93B yen implies the company is building capacity during a demand trough, creating execution risk that returns on current capital deployment may remain suboptimal absent near-term volume recovery. The full-year guidance anticipating 36% operating income decline to 10.0B yen requires Q4 operating income of approximately 4.08B yen, representing 21% sequential decline from Q3's 5.92B yen run-rate, suggesting management expects continued pressure and making guidance achievement dependent on successful inventory monetization and cost containment in the final quarter.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.